相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
Christian Pecquet et al.
BLOOD (2023)
Life histories of myeloproliferative neoplasms inferred from phylogenies
Nicholas Williams et al.
NATURE (2022)
The longitudinal dynamics and natural history of clonal haematopoiesis
Margarete A. Fabre et al.
NATURE (2022)
In utero origin of myelofibrosis presenting in adult monozygotic twins
Nikolaos Sousos et al.
NATURE MEDICINE (2022)
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up
Morten K. Larsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury et al.
LEUKEMIA (2022)
Inferring the initiation and development of myeloproliferative neoplasms
Gurvan Hermange et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms
Hans Carl Hasselbalch et al.
BLOOD (2021)
Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms
Debra Van Egeren et al.
CELL STEM CELL (2021)
Early detection of myeloproliferative neoplasms in a Danish general population study
S. Cordua et al.
LEUKEMIA (2021)
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
Jacob Handlos Grauslund et al.
FRONTIERS IN ONCOLOGY (2021)
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia
Hannah J. Uckelmann et al.
SCIENCE (2020)
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
Lasse Kjaer
CANCERS (2020)
Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
Vibe Skov
CANCERS (2020)
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
Sabrina Cordua et al.
BLOOD (2019)
Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes
Lasse Kjaer et al.
LEUKEMIA & LYMPHOMA (2018)
Population dynamics of normal human blood inferred from somatic mutations
Henry Lee-Six et al.
NATURE (2018)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
Ilyas Chachoua et al.
BLOOD (2016)
Next-generation deep-sequencing detects multiple clones of CALR mutations in patients with BCR-ABL1 negative MPN
S. Jeromin et al.
LEUKEMIA (2016)
Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms
Marito Araki et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation
P. Hirsch et al.
LEUKEMIA (2016)
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment
Lasse Kjaer et al.
PLOS ONE (2016)
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations
Emmanuelle Verger et al.
BLOOD (2015)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study
Henrik Frederiksen et al.
LANCET HAEMATOLOGY (2015)
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
Elisa Rumi et al.
BLOOD (2014)
JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate
Camilla Nielsen et al.
HAEMATOLOGICA (2014)
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations
Hajnalka Andrikovics et al.
HAEMATOLOGICA (2014)
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
A. Tefferi et al.
LEUKEMIA (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
分享论文
